Y-Intercept (HK)’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
SI
EA
KPP
DC
HPC
HWAM
BP
SWM
1IA
FFA
Y-Intercept (HK)'s IRMD Position: Q2 2026 in Review
Y-Intercept (HK) increased its iRadimed (IRMD) stake by 581% in Q2 2026, buying an estimated $1.83M and bringing the position to 23,617 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #634.
Y-Intercept (HK) first reported a position in IRMD in Q2 2024 and has held it in 3 quarters since. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Y-Intercept (HK) held 23,617 shares of iRadimed worth $2.26M as of Q2 2026.
- Y-Intercept (HK) bought 20,147 iRadimed shares in Q2 2026, an estimated $1.83M.
- iRadimed made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #634 holding.
- Y-Intercept (HK) first reported a position in iRadimed in Q2 2024 and has held it in 3 quarters since.
- 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.